drugset / Trial / NCT01770392
Relative Bioavailability of a Single Dose of Nintedanib Given Alone and in Combination With Multiple Doses of Rifampicin
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To investigate the effect of the P-gp inducer rifampicin on the pharmacokinetic parameters of nintedanib
Timeline
- Start
- 2013-01
- Primary completion
- 2013-03
- Completion
- 2013-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Nintedanib | Small molecule | 150 mg | Oral |
| Comparator | Rifampin | Small molecule | 600 mg | Oral |
Indications
No indication recorded.